Fresh Equities
Raises
Research
About
Looking for more information?

Contact our responsive and friendly client services team any time.

CANN GROUP LIMITED

INVESTOR PRESENTATION - CANN GROUP LIMITED

ASX:CAN

CANN GROUP LIMITED

Health Care

Cann Group Limited (CAN) is the first Australian company focused on breeding, cultivating and manufacturing medicinal cannabis for sale and use within Australia. The company hasestablished research and cultivation facilities in Melbourne and is striving to provide access to medicinal cannabis for Australian patients. Cann Group has executed collaboration agreements that will enable it to establish a leading position in plant genetics, breeding, extraction, analysis and production techniques required to facilitate the supply of medicinal cannabis for a range of diseases and medical conditions.

Read more

Market Cap

80.97m

Price at Close

$0.3

4w avg. Volume

1.24m

4w avg. Turnover

$451.52k

Announcements
announcementt+2 movementdate
  • Notice of Annual General Meeting & Proxy Form

    Notice Of Meeting

  • +1.32%

    21 Oct 2020

+1.32%

21 Oct 2020
  • Appendix 4C - quarterly

    Commitments test entity quarterly reports · Market sensitive

  • +1.32%

    20 Oct 2020

+1.32%

20 Oct 2020
  • Change of Director's Interest Notice

    Shareholder Details

  • 0.00%

    18 Oct 2020

0.00%

18 Oct 2020
  • Ceasing to be a substantial holder

    Shareholder Details

  • +2.63%

    13 Oct 2020

+2.63%

13 Oct 2020
  • Aurora Cannabis sells ownership position in Cann Group

    Shareholder Details · Market sensitive

  • 0.00%

    11 Oct 2020

0.00%

11 Oct 2020
  • Appendix 2A - Quotation of shares on conversion of notes

    Issued Capital

  • -1.19%

    29 Sep 2020

-1.19%

29 Sep 2020
  • Appendix 3G - Issue of options on conversion of notes

    Issued Capital

  • -1.19%

    29 Sep 2020

-1.19%

29 Sep 2020
  • Notice of forthcoming AGM and relevant dates

    Notice Of Meeting

  • -1.18%

    27 Sep 2020

-1.18%

27 Sep 2020
  • Appendix 3G - updated

    Issued Capital

  • -1.15%

    15 Sep 2020

-1.15%

15 Sep 2020
  • Change of Director's Interest Notice

    Shareholder Details

  • +2.38%

    14 Sep 2020

+2.38%

14 Sep 2020
Market Data

Current Price

$0.3

52WK HIGH

$1.835

52WK LOW

$0.29

1YR RETURN

-70.30%

1YR RETURN VS. SECTOR

-85.68%

90 DAY RETURN

-34.07%

ASX RANK

874

/2,013

SECTOR RANK

11

/30

SHARES OUTSTANDING

269.91m
ASX:CAN

CANN GROUP LIMITED

Health Care

Cann Group Limited (CAN) is the first Australian company focused on breeding, cultivating and manufacturing medicinal cannabis for sale and use within Australia. The company hasestablished research and cultivation facilities in Melbourne and is striving to provide access to medicinal cannabis for Australian patients. Cann Group has executed collaboration agreements that will enable it to establish a leading position in plant genetics, breeding, extraction, analysis and production techniques required to facilitate the supply of medicinal cannabis for a range of diseases and medical conditions.

Read more

Market Cap

80.97m

Price at Close

$0.3

4w avg. Volume

1.24m

4w avg. Turnover

$451.52k

ASX:CAN is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.